Stay ahead of Asia’s fastest-rising MedTech leaders

AsiaQCi delivers quarterly intelligence on high-growth Asian MedTech companies, helping global organisations anticipate competitive moves, evaluate opportunities, and strengthen strategy across Asia, LATAM, EMEA, and beyond.

REQUEST A DEMO
DOWNLOAD SAMPLE INSIGHTS

What is AsiaQCI?

AsiaQCi is a specialised competitive intelligence solution designed to monitor, analyse, and interpret the activities of Asia’s most influential MedTech companies.

It provides ongoing visibility into revenue trends, innovation pipelines, expansion strategies, and market dynamics—empowering global MedTech leaders to move earlier, faster, and with greater precision.

business-data-dashboard-provide-modish-business-intelligence-analytic 1

Why AsiaQCi Matters

Global MedTech players face growing competition from Asian manufacturers who are rapidly expanding into APAC, LATAM, EMEA, and emerging markets. AsiaQCi helps you:

icon

Track the rise of high-value Asian competitors in real time

icon

Identify early signals of market entry and expansion

icon

Evaluate potential M&A, partnerships, and distribution opportunities

icon

Understand how Asian MedTechs are reshaping affordability, speed, and localisation strategies

With AsiaQCi, your teams stay ahead—not caught off-guard.

What AsiaQCi Delivers

1-3

Quarterly Market Dashboards

Clear, data-rich tracking of revenue, performance, and product segments across leading companies.

2-3

Concise Qualitative Reports

Quarterly analysis that summarises business moves, organisational changes, expansion strategies, innovation patterns, and competitive implications.

3-3

Weekly Market Newsletter

Bite-sized intelligence covering product launches, distributor announcements, marketing campaigns, localisation activity, regulatory updates, and more.

Areas of Intelligence Coverage

AsiaQCi monitors the activity that matters most to commercial and strategy teams:

icon

Product innovation and R&D efforts

icon

Financial and operational performance

icon

Marketing programmes, events, and promotional activities

icon

Market expansion strategies regionally and globally

icon

Partnerships, M&A, leadership changes, and ecosystem movements

This combination provides a complete view of both performance and intent.

Companies Tracked in AsiaQCi

Surgical Companies

Leading Asian players across surgical devices, implants, robotics, and equipment:

icon MicroPort
icon Lepu Medical
icon Lifetech Scientific
icon Wego Medical
icon Bluesail
icon Double Medical
icon APT Medical
icon Fullbright Medical
icon Reach Surgicals
icon Meril

IVD Companies

Top clinical diagnostics, molecular diagnostics, POCT, and tissue diagnostics innovators:

icon Mindray
icon Snibe
icon Autobio
icon Dirui
icon YHLO
icon Maccura
icon Wondfo
icon Seegene
icon Hybribio
icon Sansure
icon SD Biosensor

Who Uses AsiaQCi

AsiaQCi is built for senior leaders who need clarity in fast-changing markets:

1-1

Corporate Strategy

2-1

Competitive Intelligence & Insights

3-1

Business Development and M&A

4-1

Regional and Global Commercial Leadership

Trusted by Global MedTech Leaders

AsiaQCi is used by multinational MedTech organisations to decode competitor momentum, sharpen strategic planning, and evaluate emerging threats and opportunities across Asia’s dynamic healthcare landscape.

man-drawing-graph 1

See AsiaQCi in Action

Experience how AsiaQCi transforms competitive monitoring into actionable insight.

REQUEST A DEMO

Related Clearstate Products

Surgical

Track surgical procedure volumes and device forecasts by hospital to inform strategic planning.

AsiaQCi

Specialized solution tracking Asian medical device companies, products, and innovation movements.

LabPRO

Comprehensive lab profiling and datasets that power precision insights across regions.

Bespoke Research

Tailored market research solutions crafted for your specific business questions and goals.

Our Global Presence

Today, Clearstate is a trusted partner to leading MedTech and life sciences companies across 50+ countries in Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America. Our specialised datasets cover 300,000+ data points across IVD, surgical, and bioprocess markets, helping clients navigate opportunities with precision.

With a track record of supporting 100+ global healthcare clients, we combine international reach with on-the-ground expertise. By delivering evidence-driven intelligence and strategic advisory, Clearstate empowers healthcare leaders to anticipate market shifts, capture opportunities, and bring innovations that improve lives worldwide.